Zhengye Biotechnology Holding Limited (ZYBT) Stock

NASDAQ: ZYBTHealthcare company in the specialty & generic drug manufacturers industry, based in Jilin, USA.

Zhengye Biotechnology stock price chart

ZYBT stock quote & key statistics

Zhengye Biotechnology earnings per share

Income →
Earnings per share

Zhengye Biotechnology revenue & net income

Income →
RevenueNet income

Zhengye Biotechnology annual financials

Income statement →
Zhengye Biotechnology Holding Limited revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$116.4M-$69.8M—
FY2024$186.4M$11.3M—
FY2023$211.7M$31.5M—
FY2022$260.3M$46.7M—
FY2021$214.1M$39.0M—

Fiscal year ending December 31. Source: company filings via EODHD.

About Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs.

In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Zhengye Biotechnology stock FAQ

What is the Zhengye Biotechnology stock ticker symbol?

Zhengye Biotechnology Holding Limited trades on the NASDAQ under the ticker symbol ZYBT.

What sector and industry is Zhengye Biotechnology in?

Zhengye Biotechnology Holding Limited is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.

How many employees does Zhengye Biotechnology have?

Zhengye Biotechnology Holding Limited has about 269 full-time employees.

What were Zhengye Biotechnology's revenue and earnings last fiscal year?

Zhengye Biotechnology reported revenue of $116.4M and net income of -$69.8M in fiscal 2025. Revenue declined 37.6% from the prior year.

When did Zhengye Biotechnology go public?

Zhengye Biotechnology stock began trading on January 7, 2025.

Drug Manufacturers - Specialty & Generic stocks

All Healthcare stocks →